Relmada Therapeutics, Inc. (RLMD)
7.03
+0.69
(+10.88%)
USD |
NASDAQ |
May 19, 16:00
7.035
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Total Liabilities (Quarterly) : 16.63M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 181.72M |
| AN2 Therapeutics, Inc. | 5.732M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
| Johnson & Johnson | 119.71B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 235.36M |
| Shareholders Equity (Quarterly) | 218.73M |
| Current Ratio | 18.26 |